Lee's Pharmaceutical Holdings Limited (0950.HK)
HKD 1.36
(2.26%)
HKD 1.36
(2.26%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.03 HKD | -67.39% |
| 2022 | 0.09 HKD | -97.42% |
| 2021 | 3.38 HKD | 2500.0% |
| 2020 | 0.13 HKD | 18.18% |
| 2019 | 0.11 HKD | -84.51% |
| 2018 | 0.71 HKD | 82.05% |
| 2017 | 0.39 HKD | -9.3% |
| 2016 | 0.43 HKD | 7.5% |
| 2015 | 0.40 HKD | 11.11% |
| 2014 | 0.36 HKD | 28.57% |
| 2013 | 0.28 HKD | 21.74% |
| 2012 | 0.23 HKD | 27.78% |
| 2011 | 0.18 HKD | 38.46% |
| 2010 | 0.13 HKD | 18.18% |
| 2009 | 0.11 HKD | 62.48% |
| 2008 | 0.07 HKD | 117.68% |
| 2007 | 0.03 HKD | 411.0% |
| 2006 | -0.01 HKD | -2600.0% |
| 2005 | 0.00 HKD | 103.81% |
| 2004 | -0.01 HKD | 43.24% |
| 2003 | -0.02 HKD | -31.21% |
| 2002 | -0.01 HKD | -95.83% |
| 2001 | -0.01 HKD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 Q4 | 0.00 HKD | 0.0% |
| 2023 Q2 | 0.01 HKD | 0.0% |
| 2023 Q1 | 0.01 HKD | 162.84% |
| 2023 FY | - HKD | -67.39% |
| 2023 Q3 | 0.00 HKD | -96.35% |
| 2022 Q4 | -0.02 HKD | -137.52% |
| 2022 Q1 | 0.03 HKD | 111.13% |
| 2022 Q2 | 0.01 HKD | -68.41% |
| 2022 Q3 | 0.06 HKD | 433.03% |
| 2022 FY | - HKD | -97.42% |
| 2021 Q2 | 3.59 HKD | 5043.27% |
| 2021 Q4 | -0.31 HKD | -1419.15% |
| 2021 FY | - HKD | 2500.0% |
| 2021 Q3 | 0.02 HKD | -99.35% |
| 2021 Q1 | 0.07 HKD | 462.9% |
| 2020 FY | - HKD | 18.18% |
| 2020 Q1 | 0.07 HKD | 14.14% |
| 2020 Q2 | 0.10 HKD | 43.22% |
| 2020 Q3 | 0.04 HKD | -56.23% |
| 2020 Q4 | 0.01 HKD | -70.82% |
| 2019 FY | - HKD | -84.51% |
| 2019 Q3 | 0.07 HKD | 586.3% |
| 2019 Q4 | 0.06 HKD | -16.34% |
| 2019 Q1 | 0.08 HKD | -78.57% |
| 2019 Q2 | -0.01 HKD | -118.41% |
| 2018 Q4 | 0.37 HKD | 208.33% |
| 2018 Q2 | 0.09 HKD | -21.75% |
| 2018 Q1 | 0.12 HKD | 55.24% |
| 2018 FY | - HKD | 82.05% |
| 2018 Q3 | 0.12 HKD | 27.8% |
| 2017 Q2 | 0.13 HKD | 65.39% |
| 2017 Q1 | 0.08 HKD | -19.8% |
| 2017 FY | - HKD | -9.3% |
| 2017 Q3 | 0.10 HKD | -23.08% |
| 2017 Q4 | 0.08 HKD | -22.7% |
| 2016 Q4 | 0.10 HKD | -18.33% |
| 2016 Q3 | 0.12 HKD | 0.0% |
| 2016 Q1 | 0.09 HKD | -17.73% |
| 2016 Q2 | 0.12 HKD | 32.6% |
| 2016 FY | - HKD | 7.5% |
| 2015 FY | - HKD | 11.11% |
| 2015 Q3 | 0.11 HKD | 0.0% |
| 2015 Q2 | 0.11 HKD | 50.27% |
| 2015 Q1 | 0.07 HKD | -26.8% |
| 2015 Q4 | 0.11 HKD | 0.0% |
| 2014 Q2 | 0.08 HKD | 6.29% |
| 2014 Q3 | 0.09 HKD | 9.9% |
| 2014 Q4 | 0.10 HKD | 9.89% |
| 2014 FY | - HKD | 28.57% |
| 2014 Q1 | 0.08 HKD | 7.75% |
| 2013 Q2 | 0.08 HKD | 28.06% |
| 2013 Q3 | 0.07 HKD | -11.21% |
| 2013 Q4 | 0.07 HKD | 2.55% |
| 2013 FY | - HKD | 21.74% |
| 2013 Q1 | 0.06 HKD | 14.39% |
| 2012 FY | - HKD | 27.78% |
| 2012 Q3 | 0.06 HKD | -2.76% |
| 2012 Q1 | 0.05 HKD | -8.55% |
| 2012 Q2 | 0.06 HKD | 17.75% |
| 2012 Q4 | 0.05 HKD | -9.67% |
| 2011 Q1 | 0.04 HKD | 0.0% |
| 2011 Q4 | 0.06 HKD | 13.92% |
| 2011 FY | - HKD | 38.46% |
| 2011 Q2 | 0.04 HKD | -3.04% |
| 2011 Q3 | 0.05 HKD | 43.3% |
| 2010 FY | - HKD | 18.18% |
| 2010 Q2 | 0.03 HKD | 0.0% |
| 2009 Q2 | 0.03 HKD | 0.0% |
| 2009 FY | - HKD | 62.48% |
| 2008 FY | - HKD | 117.68% |
| 2007 FY | - HKD | 411.0% |
| 2006 FY | - HKD | -2600.0% |
| 2005 FY | - HKD | 103.81% |
| 2004 FY | - HKD | 43.24% |
| 2003 FY | - HKD | -31.21% |
| 2002 FY | - HKD | -95.83% |
| 2001 FY | - HKD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 0.34 HKD | 91.647% |
| Grand Pharmaceutical Group Limited | 0.54 HKD | 94.741% |
| Extrawell Pharmaceutical Holdings Limited | -0.07 HKD | 141.642% |
| Wai Yuen Tong Medicine Holdings Limited | -0.01 HKD | 318.462% |
| Qianhai Health Holdings Limited | -0.03 HKD | 191.318% |
| Essex Bio-Technology Limited | 0.49 HKD | 94.204% |
| Tongfang Kontafarma Holdings Limited | -0.01 HKD | 646.154% |
| PuraPharm Corporation Limited | -0.27 HKD | 110.519% |
| SSY Group Limited | 0.44 HKD | 93.545% |
| JBM (Healthcare) Limited | 0.15 HKD | 81.067% |
| Jacobson Pharma Corporation Limited | 0.12 HKD | 76.333% |
| China Resources Pharmaceutical Group Limited | 0.68 HKD | 95.824% |